Keith Michael Gottesdiener

Insider Reports History

Location
New York, NY
Signature
/s/ Gil M. Labrucherie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Michael Gottesdiener:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Common Stock 2,310,837 $14,442,731 $6.25 08 Oct 2024 Direct
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Common Stock 682,259 $4,264,119 $6.25 08 Oct 2024 By Trust
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Common Stock 50,241 $314,006 $6.25 08 Oct 2024 By Spouse
Prime Medicine, Inc. Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director Stock Option (right to buy) 300,000 08 May 2025 Direct
Septerna, Inc. Director Stock Option (Right to Buy) 33,246 25 Sep 2025 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 08 Nov 2023 Direct

Insider Reports Filed by Keith Michael Gottesdiener

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SEPN Septerna, Inc. 25 Sep 2025 1 $0 4 Director 29 Sep 2025, 16:59
SEPN Septerna, Inc. 25 Sep 2025 0 $0 3 Director 29 Sep 2025, 16:57
PRME Prime Medicine, Inc. 08 May 2025 1 $0 4 Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director 12 May 2025, 16:50
PRME Prime Medicine, Inc. 28 Feb 2025 1 $0 4 President and Chief Executive Officer, Director 04 Mar 2025, 16:15
PRME Prime Medicine, Inc. 05 Dec 2024 1 $0 4 Officer, Director 09 Dec 2024, 18:23
PRME Prime Medicine, Inc. 08 Oct 2024 2 $0 4 President and Chief Executive Officer, Director 10 Oct 2024, 16:29
PRME Prime Medicine, Inc. 05 Jun 2024 2 $0 4 President and Chief Executive Officer, Director 07 Jun 2024, 16:18
PRME Prime Medicine, Inc. 25 Feb 2024 1 $0 4 President and Chief Executive Officer, Director 27 Feb 2024, 09:35
PRME Prime Medicine, Inc. 11 Nov 2023 2 $0 4 Officer, Director 14 Nov 2023, 20:11
/report/000110465923117102-gottesdiener-keith-michael-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 10 -$623,770 4 Director 13 Nov 2023, 14:43
/report/000110465923064844-gottesdiener-keith-michael-2023-05-24 INTERCEPT PHARMACEUTICALS, INC. 24 May 2023 2 $0 4 Director 25 May 2023, 20:40
PRME Prime Medicine, Inc. 31 Mar 2023 1 $0 4 President and Chief Executive Officer, Director 04 Apr 2023, 20:22
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3 President and Chief Executive Officer. Exhibit 24 - Power of Attorney, Director 19 Oct 2022, 20:04
/report/000110465922065902-gottesdiener-keith-michael-2022-05-25 INTERCEPT PHARMACEUTICALS, INC. 25 May 2022 2 $0 4 Director 27 May 2022, 16:16
/report/000110465921075219-gottesdiener-keith-michael-2021-05-27 INTERCEPT PHARMACEUTICALS, INC. 27 May 2021 2 $0 4 Director 01 Jun 2021, 19:02